Article info

Download PDFPDF

Original research
Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework

Authors

  • Amanj Kurdi Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UKDepartment of Pharmacology and Toxicology, College of Pharmacy, Hawler Medical University, Erbil, Iraq PubMed articlesGoogle scholar articles
  • Rachel Ann Elliott Manchester Centre for Health Economics, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Li-Chia Chen Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Li-Chia Chen; Li-chia.chen{at}manchester.ac.uk
View Full Text

Citation

Kurdi A, Elliott RA, Chen L
Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework

Publication history

  • Received November 22, 2019
  • Revised April 2, 2020
  • Accepted May 27, 2020
  • First published June 23, 2020.
Online issue publication 
June 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.